KHAN BILAL ARSHAD enters SPYGLASS PHARMA, INC. with 141.88K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 2/5/2026ACC: 0002108044-26-000002
141.88K
Baseline shares
4% direct
5.45K
Direct ownership
1 position
60.52K
Derivative underlying
2 instruments
2
Security positions
136.43K indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned136.43K
Common Stock
DirectShares owned5.45K
Total
5.45K direct·136.43K indirect141.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 136.43K | Indirect |
| Common Stock | 5.45K | Direct |
| Total | 141.88K | 5.45K direct·136.43K indirect |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
11.99K
Shares owned
N/A
Exercise price
2.18
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
48.53K
Shares owned
N/A
Exercise price
7.11
Expiration
—
Exercise window
—
Total
Underlying
60.52K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 2.18 | — | — | 11.99K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 7.11 | — | — | 48.53K | N/A |
| Total | 60.52K | 0.00 | ||||